Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Expression of Wnt5a and WNT Coreceptor (LRP5) Levels in Stage III Periodontitis Patients

NCT06933784 is registered in ClinicalTrials.gov with Ankara University as lead sponsor.

NCT NCT06933784
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06933784 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Expression of Wnt5a and WNT Coreceptor (LRP5) Levels in Stage III Periodontitis Patients
Lead sponsor
Ankara University
Phase
Observational
Overall status
Completed
Start date
April 1, 2024
Completion date
March 1, 2025
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

periodontal disease, periodontitis (stage 3), periodontitis stage iii